Brief: SCHOTT Pharma Q3 Revenues Up 3% To EUR 256 Mln
05/08/2025 08:59
Aug 5 (Reuters) - SCHOTT Pharma AG & Co KgaA 1SXP.DE: EQS-NEWS: SCHOTT PHARMA REPORTS PRELIMINARY RESULTS FOR Q3 2025 AND SPECIFIES FY 2025 GUIDANCE SCHOTT PHARMA AG & CO KGAA - Q3 2025 REVENUES UP 3% YOY AT CONSTANT CURRENCIES TO EUR 256M SCHOTT PHARMA AG & CO KGAA - Q3 2025 EBITDA UP 11% YOY TO EUR 83M SCHOTT PHARMA AG & CO KGAA - FULL SET OF Q3/9M 2025 FINANCIAL RESULTS WILL BE PUBLISHED ON AUGUST 12, 2025 Source text: ID:nEQcd4h1Na Further company coverage: 1SXP.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))